Pleiotrophin is downregulated in human keloids

Area of Science:

• Dermatology
• Molecular Biology
• Wound Healing Research

Background:

• Keloids are abnormal hyperproliferative scars with complex genetic and environmental factors.
• Pleiotrophin (PTN), a growth factor involved in cell growth and tumor progression, has controversial expression data in keloids.
• Previous studies show increased PTN in hypertrophic scars, but its role in keloids is unclear.

Purpose of the Study:

• To investigate the differential expression of PTN and its interacting molecules in keloid versus normal fibroblasts.
• To clarify the role of PTN signaling in the pathomechanism of keloid formation.

Main Methods:

• Investigated PTN and interacting molecule expression in keloid and control fibroblasts.
• Performed immunohistochemical staining of PTN on tissue arrays.
• Utilized Western blot analysis for protein expression confirmation.

Main Results:

• PTN, platelet-derived growth factor subunit B (PDGF-B), and PDGF receptors were significantly downregulated in keloid fibroblasts.
• Decreased PTN protein expression was confirmed via immunohistochemistry and Western blot.
• The downstream receptor protein tyrosine phosphatase β/ζ was upregulated, indicating PTN signaling pathway downregulation.

Conclusions:

• Keloid fibroblasts exhibit significantly lowered PTN expression compared to normal fibroblasts.
• The downregulation of PTN signaling suggests a distinct pathomechanism for keloids compared to hypertrophic scars.
• These findings highlight PTN as a potential factor differentiating keloid scarring.